Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tracon Pharmaceuticals Inc
(NQ:
TCON
)
1.430
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tracon Pharmaceuticals Inc
< Previous
1
2
Next >
TRACON Pharmaceuticals Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial
December 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma
November 21, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
October 31, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update
October 06, 2022
From
Runway Growth Finance Corp.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned
October 06, 2022
Review of Interim Efficacy Data by IDMC to Occur in Fourth Quarter
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Clinical Stage Trials, Novel Targeted Cancer Therapeutics and $25.6 Million in the Bank to Persevere this NASDAQ through 2023: TRACON Pharmaceuticals (NASDAQ: TCON)
August 31, 2021
Via
Get News
25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON)
August 31, 2021
Via
Get News
Capital Efficient: Clinical Stage NASDAQ Company – Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON)
August 16, 2021
Via
Get News
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Investor Alert: Investigation over Potential Wrongdoing
May 04, 2021
San Diego, CA -- (SBWIRE) -- 05/04/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at TRACON Pharmaceuticals, Inc.
Via
SBWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.